KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizationAmortizationCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in CashChange in IntangiblesChange in IntangiblesDivestmentsDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShares IssuedShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gsk (GSK) Acquisitions (2016 - 2026)

Gsk has reported Acquisitions over the past 14 years, most recently at -$1.9 billion for Q1 2026.

  • For Q1 2026, Acquisitions fell 87.86% year-over-year to -$1.9 billion; the TTM value through Mar 2026 reached -$3.9 billion, up 15.3%, while the annual FY2025 figure was -$2.3 billion, 117.83% down from the prior year.
  • Acquisitions for Q1 2026 was -$1.9 billion at Gsk, down from -$49.2 million in the prior quarter.
  • Over five years, Acquisitions peaked at -$49.2 million in Q4 2025 and troughed at -$1.9 billion in Q1 2026.
  • A 5-year average of -$949.9 million and a median of -$960.1 million in 2024 define the central range for Acquisitions.
  • Biggest five-year swings in Acquisitions: crashed 1797.91% in 2023 and later soared 94.87% in 2025.
  • Year by year, Acquisitions stood at -$91.5 million in 2022, then crashed by 1797.91% to -$1.7 billion in 2023, then skyrocketed by 44.71% to -$960.1 million in 2024, then soared by 94.87% to -$49.2 million in 2025, then crashed by 3745.98% to -$1.9 billion in 2026.
  • Business Quant data shows Acquisitions for GSK at -$1.9 billion in Q1 2026, -$49.2 million in Q4 2025, and -$1.0 billion in Q1 2025.